We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.5B
AUM Growth
-$1.66B
Cap. Flow
-$1.45B
Cap. Flow %
-11.6%
Top 10 Hldgs %
32.88%
Holding
1,206
New
194
Increased
593
Reduced
261
Closed
41

Top Buys

Rank Stock Value
1
BXP icon
Boston Properties
BXP
+$165M
2
PK icon
Park Hotels & Resorts
PK
+$106M
3
GGP
GGP Inc.
GGP
+$92.1M
4
HPP
Hudson Pacific Properties
HPP
+$84M
5
SITC icon
SITE Centers
SITC
+$79.5M

Top Sells

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$275M
2
MAA icon
Mid-America Apartment Communities
MAA
+$247M
3
VTR icon
Ventas
VTR
+$128M
4
EQR icon
Equity Residential
EQR
+$127M
5
HST icon
Host Hotels & Resorts
HST
+$120M

Sector Composition

Rank Sector Weight
1 Real Estate 73.13%
2 Industrials 4.58%
3 Technology 4.24%
4 Financials 3.1%
5 Healthcare 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUPH icon
1101
Aurinia Pharmaceuticals
AUPH
$1.97B
$2K ﹤0.01%
+464
New +$2.48K
AVDL
1102
DELISTED
Avadel Pharmaceuticals
AVDL
$2K ﹤0.01%
+227
New +$2K
CBUS icon
1103
Cibus
CBUS
$130M
$2K ﹤0.01%
+3
New +$3.12K
CLDX icon
1104
Celldex Therapeutics
CLDX
$2.77B
$2K ﹤0.01%
+50
New +$1.94K
CLLS
1105
Cellectis
CLLS
$286M
$2K ﹤0.01%
+49
New +$1.55K
CRBP icon
1106
Corbus Pharmaceuticals
CRBP
$170M
$2K ﹤0.01%
+10
New +$2.25K
CYTK icon
1107
Cytokinetics
CYTK
$11B
$2K ﹤0.01%
+298
New +$2.56K
IBRX icon
1108
ImmunityBio
IBRX
$7.44B
$2K ﹤0.01%
+439
New +$1.93K
IMUX icon
1109
Immunic
IMUX
$182M
$2K ﹤0.01%
+1
New +$2.29K
INO icon
1110
Inovio Pharmaceuticals
INO
$79.8M
$2K ﹤0.01%
+42
New +$2.27K
KALA icon
1111
KALA BIO
KALA
$11.8M
– –
0
– –
MCRB icon
1112
Seres Therapeutics
MCRB
$48M
$2K ﹤0.01%
+11
New +$2.11K
MRSN
1113
DELISTED
Mersana Therapeutics
MRSN
$2K ﹤0.01%
+5
New +$1.97K
SNDX icon
1114
Syndax Pharmaceuticals
SNDX
$1.84B
$2K ﹤0.01%
+135
New +$1.43K
SVRA icon
1115
Savara
SVRA
$1.13B
$2K ﹤0.01%
+169
New +$1.99K
TVRD
1116
Tvardi Therapeutics
TVRD
$23.5M
$2K ﹤0.01%
+5
New +$2.42K
PETQ
1117
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
+73
New +$1.71K
RETA
1118
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2K ﹤0.01%
+110
New +$2.83K
PRTK
1119
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2K ﹤0.01%
+173
New +$2.58K
NH
1120
DELISTED
NantHealth, Inc
NH
$2K ﹤0.01%
+40
New +$2.01K
SBBP
1121
DELISTED
Strongbridge Biopharma plc.
SBBP
$2K ﹤0.01%
+220
New +$1.65K
DERM
1122
DELISTED
Dermira, Inc.
DERM
$2K ﹤0.01%
+230
New +$5.01K
SNNA
1123
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$2K ﹤0.01%
+113
New +$1.98K
INSY
1124
DELISTED
Insys Therapeutics, Inc.
INSY
$2K ﹤0.01%
+405
New +$3.34K
SGYP
1125
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2K ﹤0.01%
+1,363
New +$2.88K
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q1 2018 Portfolio in Review

As of Q1 2018, Daiwa Securities Group held 1,206 positions worth $12.5B, down 12% from $14.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $1.45B in Q1 2018, closing 41 positions and reducing 261 holdings. Its most notable exit was Anthem, Inc., an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 77% a quarter earlier, followed by Industrials and Technology.

Against the trend, Daiwa Securities Group opened a new position in Supernus Pharmaceuticals worth $3.16M.

  • Daiwa Securities Group's largest Q1 2018 buy was Supernus Pharmaceuticals: 68,983 shares worth $3.16M.
  • Daiwa Securities Group added most to Boston Properties in Q1 2018, an estimated $165M increase.
  • Daiwa Securities Group's biggest Q1 2018 reduction was Simon Property Group, cutting an estimated $275M.
  • Daiwa Securities Group fully exited Anthem, Inc. in Q1 2018, selling an estimated $25.2M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $12.5B portfolio in Q1 2018.
  • Daiwa Securities Group opened 194 new positions and closed 41 in Q1 2018.
  • Daiwa Securities Group's portfolio value fell 12% quarter-over-quarter to $12.5B.

Based on Daiwa Securities Group's 13F filing for Q1 2018, filed 2 May 2018.